4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]

686 reported adverse events

Drugs of this class: NITISINONE

These side effects are most commonly reported by patients taking drugs of the 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] class:

#	Side effect	Count
0	AMINO ACID LEVEL INCREASED	107
1	LIVER TRANSPLANT	98
2	ALPHA 1 FOETOPROTEIN INCREASED	42
3	HEPATOCELLULAR CARCINOMA	41
4	TREATMENT NONCOMPLIANCE	36
5	HEPATIC CIRRHOSIS	34
6	LENTICULAR OPACITIES	34
7	SUCCINYLACETONE INCREASED	31
8	VOMITING	30
9	HEPATIC FAILURE	29

See all common reactions for 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]

Drugs of the 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	SUCCINYLACETONE INCREASED	31	0.9688
1	TYROSINAEMIA	4	0.5714
2	URINE DELTA AMINOLEVULINATE	2	0.2857
3	AMINO ACID LEVEL INCREASED	107	0.2730
4	METASTATIC CHORIOCARCINOMA	1	0.1667
5	AMINO ACID LEVEL DECREASED	17	0.1318
6	LENTICULAR OPACITIES	34	0.1145
7	ACRODERMATITIS ENTEROPATHICA	2	0.1111
8	HEPATIC DYSPLASIA	1	0.0909
9	ALPHA 1 FOETOPROTEIN INCREASED	42	0.0837

See all enriched reactions for 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]